...we analyzed the correlation between MPZL3 expression and drug sensitivity in the top 9 anticancer drugs from the CellMiner database. The results suggested that high MPZL3 expression could decrease the drug IC50 and increase the drug sensitivity of IDH-C227... P-529...and midostaurin...while increasing the drug IC50 and decreasing the drug sensitivity of BAY-876...SR16157...elesclomol...AZD-9496...fulvestrant...and GDC-0077.